1. Home
  2. UIS vs ARMP Comparison

UIS vs ARMP Comparison

Compare UIS & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

SELL

Current Price

$2.21

Market Cap

208.5M

Sector

Technology

ML Signal

SELL

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$3.63

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UIS
ARMP
Founded
1942
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.5M
199.7M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
UIS
ARMP
Price
$2.21
$3.63
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.81
★ $17.50
AVG Volume (30 Days)
★ 587.8K
276.2K
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $1,950,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.84
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.97
$3.14
52 Week High
$4.98
$14.98

Technical Indicators

Market Signals
Indicator
UIS
ARMP
Relative Strength Index (RSI) 32.99 38.67
Support Level $2.14 $3.38
Resistance Level $2.61 $5.63
Average True Range (ATR) 0.09 0.32
MACD 0.01 0.03
Stochastic Oscillator 13.55 29.41

Price Performance

Historical Comparison
UIS
ARMP

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: